获得用于核医学的钪同位素纳米金刚石共轭物

IF 0.9 Q4 CHEMISTRY, INORGANIC & NUCLEAR
A. G. Kazakov, T. Y. Ekatova, S. E. Vinokurov, E. Y. Khvorostinin, I. A. Ushakov, V. V. Zukau, E. S. Stasyuk, E. A. Nesterov, V. L. Sadkin, A. S. Rogov, B. F. Myasoedov
{"title":"获得用于核医学的钪同位素纳米金刚石共轭物","authors":"A. G. Kazakov,&nbsp;T. Y. Ekatova,&nbsp;S. E. Vinokurov,&nbsp;E. Y. Khvorostinin,&nbsp;I. A. Ushakov,&nbsp;V. V. Zukau,&nbsp;E. S. Stasyuk,&nbsp;E. A. Nesterov,&nbsp;V. L. Sadkin,&nbsp;A. S. Rogov,&nbsp;B. F. Myasoedov","doi":"10.1134/S1066362224020103","DOIUrl":null,"url":null,"abstract":"<p>In this work, we studied the sorption of scandium, whose isotopes <sup>44</sup>Sc and <sup>47</sup>Sc are explored for diagnostics and therapy in nuclear medicine, by aggregates of commercial (TAN, STP) and oxidized nanodiamonds (ox-STP) from aqueous solutions. The sorption capacity of the studied NDs for scandium was determined; 100 μg of NDs is found to be sufficient for the sorption of 1 GBq of <sup>47</sup>Sc, which is equivalent to the activity of isotopes used in therapy. It was shown that the supposed mechanism for the binding of Sc(III) to nanodiamond aggregates is chemisorption, and the chemical composition of the nanodiamond surface affects the sorption efficiency to a greater extent than the speciation of scandium in solution. The obtained data on Sc(III) sorption are correlated with the sizes of nanodiamond aggregates; it is shown that sorption under experimental conditions does not depend on the size of the aggregates. For the further development of radiopharmaceuticals based on <sup>47</sup>Sc, optimal carriers for this isotope—TAN and ox-STP—were suggested.</p>","PeriodicalId":747,"journal":{"name":"Radiochemistry","volume":"66 2","pages":"206 - 211"},"PeriodicalIF":0.9000,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Obtaining of Nanodiamond Conjugates with Scandium Isotopes for the Use in Nuclear Medicine\",\"authors\":\"A. G. Kazakov,&nbsp;T. Y. Ekatova,&nbsp;S. E. Vinokurov,&nbsp;E. Y. Khvorostinin,&nbsp;I. A. Ushakov,&nbsp;V. V. Zukau,&nbsp;E. S. Stasyuk,&nbsp;E. A. Nesterov,&nbsp;V. L. Sadkin,&nbsp;A. S. Rogov,&nbsp;B. F. Myasoedov\",\"doi\":\"10.1134/S1066362224020103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In this work, we studied the sorption of scandium, whose isotopes <sup>44</sup>Sc and <sup>47</sup>Sc are explored for diagnostics and therapy in nuclear medicine, by aggregates of commercial (TAN, STP) and oxidized nanodiamonds (ox-STP) from aqueous solutions. The sorption capacity of the studied NDs for scandium was determined; 100 μg of NDs is found to be sufficient for the sorption of 1 GBq of <sup>47</sup>Sc, which is equivalent to the activity of isotopes used in therapy. It was shown that the supposed mechanism for the binding of Sc(III) to nanodiamond aggregates is chemisorption, and the chemical composition of the nanodiamond surface affects the sorption efficiency to a greater extent than the speciation of scandium in solution. The obtained data on Sc(III) sorption are correlated with the sizes of nanodiamond aggregates; it is shown that sorption under experimental conditions does not depend on the size of the aggregates. For the further development of radiopharmaceuticals based on <sup>47</sup>Sc, optimal carriers for this isotope—TAN and ox-STP—were suggested.</p>\",\"PeriodicalId\":747,\"journal\":{\"name\":\"Radiochemistry\",\"volume\":\"66 2\",\"pages\":\"206 - 211\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2024-05-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiochemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://link.springer.com/article/10.1134/S1066362224020103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, INORGANIC & NUCLEAR\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiochemistry","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1134/S1066362224020103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
引用次数: 0

摘要

摘要 在这项工作中,我们研究了商用纳米金刚石(TAN、STP)和氧化纳米金刚石(ox-STP)聚集体从水溶液中吸附钪的情况,钪的同位素 44Sc 和 47Sc 在核医学中被用于诊断和治疗。测定了所研究的纳米金刚石对钪的吸附能力;发现 100 μg 的纳米金刚石足以吸附 1 GBq 的 47Sc,这相当于用于治疗的同位素的活性。研究表明,Sc(III)与纳米金刚石聚集体结合的假定机制是化学吸附,纳米金刚石表面的化学成分对吸附效率的影响程度大于溶液中钪的种类。所获得的 Sc(III) 吸附数据与纳米金刚石聚集体的大小相关;实验表明,实验条件下的吸附与聚集体的大小无关。为进一步开发基于 47Sc 的放射性药物,提出了该同位素的最佳载体--TAN 和 ox-STP。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Obtaining of Nanodiamond Conjugates with Scandium Isotopes for the Use in Nuclear Medicine

Obtaining of Nanodiamond Conjugates with Scandium Isotopes for the Use in Nuclear Medicine

Obtaining of Nanodiamond Conjugates with Scandium Isotopes for the Use in Nuclear Medicine

In this work, we studied the sorption of scandium, whose isotopes 44Sc and 47Sc are explored for diagnostics and therapy in nuclear medicine, by aggregates of commercial (TAN, STP) and oxidized nanodiamonds (ox-STP) from aqueous solutions. The sorption capacity of the studied NDs for scandium was determined; 100 μg of NDs is found to be sufficient for the sorption of 1 GBq of 47Sc, which is equivalent to the activity of isotopes used in therapy. It was shown that the supposed mechanism for the binding of Sc(III) to nanodiamond aggregates is chemisorption, and the chemical composition of the nanodiamond surface affects the sorption efficiency to a greater extent than the speciation of scandium in solution. The obtained data on Sc(III) sorption are correlated with the sizes of nanodiamond aggregates; it is shown that sorption under experimental conditions does not depend on the size of the aggregates. For the further development of radiopharmaceuticals based on 47Sc, optimal carriers for this isotope—TAN and ox-STP—were suggested.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Radiochemistry
Radiochemistry CHEMISTRY, INORGANIC & NUCLEAR-
CiteScore
1.30
自引率
33.30%
发文量
51
期刊介绍: Radiochemistry  is a journal that covers the theoretical and applied aspects of radiochemistry, including basic nuclear physical properties of radionuclides; chemistry of radioactive elements and their compounds; the occurrence and behavior of natural and artificial radionuclides in the environment; nuclear fuel cycle; radiochemical analysis methods and devices; production and isolation of radionuclides, synthesis of labeled compounds, new applications of radioactive tracers; radiochemical aspects of nuclear medicine; radiation chemistry and after-effects of nuclear transformations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信